Sutureless Closure for Primary Total Anomalous Pulmonary Venous Connection
TAPVC
Short-term and Mid-term Outcome of Sutureless Closure for Primary Total Anomalous Pulmonary Venous Connection
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to assess the percentage of pulmonary venous stenosis after TAPVC repair with sutureless closure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2019
CompletedFirst Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
June 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJune 25, 2021
June 1, 2021
3 years
June 16, 2021
June 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The percentage of pulmonary venous stenosis after reparing TAPVC with sutureless technique
The investigators calculate pulmonary venous score (PVS) based on the mean gradient through each pulmonary vein. Then we sum all the score of each pulmonary vein, range from 0 to 12, and classify to 4 levels. Score 0 if the mean gradient is less than 2mmHg, 1 if it is from 2 to 6,9mmHg, 2 if it is from 7 mmHg and above, and 3 if the vein is occluded. The degree of obstruction is classified as follow: none (0 to 1), mild (2 to 3), moderate (4 to 7), and severe (from 8 and above).
The investigators assess the PVS at the time of 12 month after the operation.
Early mortality (<30 days)
Early mortality is defined when patients die within 30 days since the operation
30 days
The percentage of pulmonary venous stenosis after reparing TAPVC with sutureless technique
The investigator calculate pulmonary venous score (PVS) based on the mean gradient through each pulmonary vein. Then we sum all the score of each pulmonary vein, range from 0 to 12, and classify to 4 levels. Score 0 if the mean gradient is less than 2mmHg, 1 if it is from 2 to 6,9mmHg, 2 if it is from 7 mmHg and above, and 3 if the vein is occluded. The degree of obstruction is classified as follow: none (0 to 1), mild (2 to 3), moderate (4 to 7), and severe (from 8 and above).
The investigators assess the PVS at the time of 18 month after the operation.
Secondary Outcomes (2)
Late mortality (> 30 days)
The investigators assess mortality at the time of 18 month after the operation
The percentage of pulmonary venous stenosis after reparing TAPVC with sutureless technique
The investigators assess the PVS at the time of 6 month after the operation.
Eligibility Criteria
All patients with TAPVC operated with sutureless closure and be agreed to joint this study by parents from 01/2019 to 06/2024
You may qualify if:
- All patients with TAPVC operated with sutureless closure and be agreed to join this study by parents from 01/2019 to 06/2024.
You may not qualify if:
- TAPVC operated with sutureless closure have single ventricle, isomerism or heterotaxy, congenital pulmonary venous stenosis.
- TAPVC enrolled to study but cannot the obtain the echocardiography at the time of 1 month, 6 month, 12 month and 18 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital 1
Ho Chi Minh City, 70000, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Thoi K Ngo, MSC
Children's Hospital 1
- STUDY DIRECTOR
Phuc M Vu, PhD
University of Medicine and Pharmacy in HCMC
- STUDY DIRECTOR
Tuan D Nguyen, MSC
Children's Hospital 1
- STUDY DIRECTOR
Linh NU Truong, PhD
University of Medicine and Pharmacy in HCMC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 18 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
June 16, 2021
First Posted
June 25, 2021
Study Start
May 30, 2019
Primary Completion
June 1, 2022
Study Completion
June 1, 2024
Last Updated
June 25, 2021
Record last verified: 2021-06